Skip to main content
Day.News — Local News. Real Community.
247 neighbors reading now

Columbus Day News

Terps territory: Education, Innovation, and Community.Columbus, OH Edition
health
5 min read

CDC to Provide Update on Novel H1N1 Influenza Cases

June 13, 2026

Atlanta — The CDC announced plans to host a telephone briefing to provide an update on the investigation of novel influenza A (H1N1) cases. The briefing will cover key findings from a new Morbidity and Mortality Weekly Report (MMWR). The report focuses on novel influenza A (H1N1) virus infections among healthcare personnel in the United States during April and May 2009.

The CDC will use the briefing to communicate the latest data and analysis related to the spread and impact of the H1N1 virus. The agency aims to inform healthcare professionals and the public about the virus and measures to prevent its spread.

Further details regarding the briefing, including the time and call-in information, will be released by the CDC shortly.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

0 ratings submitted

How do you feel about this story?

NA

National Desk

Trust 3.249779 articles1,581,888 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

U

Be respectful and thoughtful in your comments.

Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Upcoming Events

Advertisement
Sponsor Message

Related Stories

Weekly Semaglutide Improves Quality of Life for Patients With Diabetes and Kidney Disease

Weekly Semaglutide Improves Quality of Life for Patients With Diabetes and Kidney Disease

Semaglutid improves quality of life for patients with diabetes and kidney disease, study finds

Semaglutid improves quality of life for patients with diabetes and kidney disease, study finds

Semaglutide Study Shows Quality-of-Life Improvements in Diabetic Patients With Kidney Disease

Semaglutide Study Shows Quality-of-Life Improvements in Diabetic Patients With Kidney Disease